- Home
- MSLE vs ZNTL Comparison
MSLE vs ZNTL Comparison
Compare MSLE & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$2.37
Company Overview
Basic Information| Metric | MSLE | ZNTL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.9M | 156.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MSLE | ZNTL |
|---|---|---|
| Price | $12.39 | $2.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 60.2K | ★ 614.0K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.87 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,425,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.64 | $1.01 |
| 52 Week High | $12.22 | $3.95 |
Technical Indicators
Market Signals| Indicator | MSLE | ZNTL |
|---|---|---|
| Relative Strength Index (RSI) | 72.02 | 46.91 |
| Support Level | $11.05 | $1.27 |
| Resistance Level | N/A | $2.69 |
| Average True Range (ATR) | 0.63 | 0.17 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 95.88 | 32.29 |
Price Performance
Historical Comparison MSLE
ZNTL
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.